Donald Trump’s Presidency Could Unleash a Pharma Merger Boom — Fortune

Biotechnology companies, whose U.S. shares soared Wednesday after Republican Donald Trump’s presidential election, may soon see another benefit: an uptick in biotech M&A. A potential influx of foreign cash and improved stock valuations under the Trump administration would likely boost dealmaking in the industry, which has been anemic ever since political rhetoric against high drug…

via Donald Trump’s Presidency Could Unleash a Pharma Merger Boom — Fortune

Advertisements